Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• Päätekijät: Min-Lan Tsai (Tekijä), Hsiu-Chen Lin (Tekijä), Chiung-Hui Yen (Tekijä), Jung-Tzu Ku (Tekijä), Shian-Ying Sung (Tekijä), Hsi Chang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2022-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...